These results indicate that systemic expression of the Ghrelin-IGF-1 growth axis is altered in the terminal stage of AE, potentially relating to disease progression and serving as a protective mechanism to limit parasitic disease advancement. The gene discussed is GHRL; the disease is parasitic infectious disease.